JAMJOOM PHARMACEUTICALS FACTORY CO. financial statements, including revenue, expenses, profit, and loss

The total revenue of 4015 for the last quarter is 385.46 M SAR, and it's 85.45% higher compared to the previous quarter. The net income of Q1 24 is 102.97 M SAR.